Abbott Laboratories (ABT)
NYSE: ABT · IEX Real-Time Price · USD
109.62
+0.73 (0.67%)
Apr 16, 2024, 2:31 PM EDT - Market open
Abbott Laboratories Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 1994 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 7,279 | 10,170 | 10,249 | 7,148 | 4,140 | 4,086 | 9,610 | 18,775 | 6,125 | 4,460 | Upgrade
|
| Cash & Cash Equivalents | 7,279 | 10,170 | 10,249 | 7,148 | 4,140 | 4,086 | 9,610 | 18,775 | 6,125 | 4,460 | Upgrade
|
| Cash Growth | -28.43% | -0.77% | 43.38% | 72.66% | 1.32% | -57.48% | -48.81% | 206.53% | 37.33% | -44.92% | Upgrade
|
| Receivables | 6,565 | 6,218 | 6,487 | 6,414 | 5,425 | 5,182 | 5,249 | 3,248 | 3,418 | 3,586 | Upgrade
|
| Inventory | 6,570 | 6,173 | 5,157 | 5,012 | 4,316 | 3,796 | 3,601 | 2,434 | 2,599 | 2,643 | Upgrade
|
| Other Current Assets | 2,256 | 2,663 | 2,346 | 1,867 | 1,786 | 1,568 | 1,687 | 2,319 | 2,013 | 2,867 | Upgrade
|
| Total Current Assets | 22,670 | 25,224 | 24,239 | 20,441 | 15,667 | 14,632 | 20,147 | 26,776 | 14,155 | 13,556 | Upgrade
|
| Property, Plant & Equipment | 10,154 | 9,162 | 8,959 | 9,029 | 8,038 | 7,563 | 7,607 | 5,705 | 5,730 | 5,935 | Upgrade
|
| Long-Term Investments | 799 | 766 | 816 | 821 | 883 | 897 | 883 | 2,947 | 4,041 | 229 | Upgrade
|
| Goodwill and Intangibles | 32,494 | 33,253 | 35,970 | 38,528 | 40,220 | 42,196 | 45,493 | 12,222 | 15,200 | 16,265 | Upgrade
|
| Other Long-Term Assets | 7,097 | 6,033 | 5,212 | 3,729 | 3,079 | 1,885 | 2,120 | 5,016 | 2,121 | 5,222 | Upgrade
|
| Total Long-Term Assets | 50,544 | 49,214 | 50,957 | 52,107 | 52,220 | 52,541 | 56,103 | 25,890 | 27,092 | 27,651 | Upgrade
|
| Total Assets | 73,214 | 74,438 | 75,196 | 72,548 | 67,887 | 67,173 | 76,250 | 52,666 | 41,247 | 41,207 | Upgrade
|
| Accounts Payable | 4,295 | 4,607 | 4,408 | 3,946 | 3,252 | 2,975 | 2,402 | 1,178 | 1,081 | 1,064 | Upgrade
|
| Current Debt | 1,080 | 2,251 | 754 | 220 | 1,478 | 207 | 714 | 1,325 | 3,130 | 4,437 | Upgrade
|
| Other Current Liabilities | 8,466 | 8,631 | 7,943 | 7,741 | 6,133 | 5,830 | 5,796 | 4,157 | 4,975 | 4,966 | Upgrade
|
| Total Current Liabilities | 13,841 | 15,489 | 13,105 | 11,907 | 10,863 | 9,012 | 8,912 | 6,660 | 9,186 | 10,467 | Upgrade
|
| Long-Term Debt | 13,599 | 14,522 | 17,296 | 18,527 | 16,661 | 19,359 | 27,210 | 20,681 | 5,871 | 3,393 | Upgrade
|
| Other Long-Term Liabilities | 6,947 | 7,522 | 8,771 | 9,111 | 9,062 | 8,080 | 9,030 | 4,608 | 4,864 | 5,708 | Upgrade
|
| Total Long-Term Liabilities | 20,546 | 22,044 | 26,067 | 27,638 | 25,723 | 27,439 | 36,240 | 25,289 | 10,735 | 9,101 | Upgrade
|
| Total Liabilities | 34,387 | 37,533 | 39,172 | 39,545 | 36,586 | 36,451 | 45,152 | 31,949 | 19,921 | 19,568 | Upgrade
|
| Total Debt | 14,679 | 16,773 | 18,050 | 18,747 | 18,139 | 19,566 | 27,924 | 22,006 | 9,001 | 7,830 | Upgrade
|
| Debt Growth | -12.48% | -7.07% | -3.72% | 3.35% | -7.29% | -29.93% | 26.89% | 144.48% | 14.96% | 19.34% | Upgrade
|
| Retained Earnings | 37,554 | 35,257 | 31,528 | 27,627 | 25,847 | 24,560 | 23,978 | 25,565 | 25,757 | 22,874 | Upgrade
|
| Comprehensive Income | -7,839 | -8,051 | -8,374 | -8,946 | -8,465 | -7,586 | -6,062 | -7,263 | -6,658 | -5,053 | Upgrade
|
| Shareholders' Equity | 38,827 | 36,905 | 36,024 | 33,003 | 31,301 | 30,722 | 31,098 | 20,717 | 21,326 | 21,639 | Upgrade
|
| Net Cash / Debt | -7,400 | -6,603 | -7,801 | -11,599 | -13,999 | -15,480 | -18,314 | -3,231 | -2,876 | -3,370 | Upgrade
|
| Net Cash Per Share | -4.23 | -3.74 | -4.36 | -6.49 | -7.86 | -8.75 | -10.47 | -2.18 | -1.91 | -2.21 | Upgrade
|
| Working Capital | 8,829 | 9,735 | 11,134 | 8,534 | 4,804 | 5,620 | 11,235 | 20,116 | 4,969 | 3,089 | Upgrade
|
| Book Value Per Share | 22.31 | 21.05 | 20.30 | 18.61 | 17.70 | 17.48 | 17.87 | 14.03 | 14.26 | 14.27 | Upgrade
|